Developer docs
API playgroundTry for free, no card

Search company profiles

PharmaDirections

Full company profile

uuid0006prf

Namestring
PharmaDirections
Legal namestring
PharmaDirections, Inc.
Company typeenum
Private
Founded yearint
2003
Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCary, United States
HQ citystring
Cary
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
drug development consulting, pharmaceutical regulatory affairs, preclinical research services, CMC consulting services, biotech program management
Industry1 code
PRIMARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Drug Development Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Drug Development Consulting Services
TypeProfessional Services
Description

Professional services revenue from providing virtual drug development expertise to small biotech companies. Services span from discovery through commercialization, including regulatory affairs, CMC, preclinical, program management, and strategic consulting.

pharmadirections.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PharmaDirections is a virtual drug development company that provides consulting and execution services to small, start-up, and micro-biotech companies. The firm delivers expert support across the full drug development lifecycle, from discovery through regulatory approval, acting as an outsourced drug development partner for resource-constrained biotech sponsors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 45+ patents and patent applications generated for clients
+3 more records
Product overview1 text field

PharmaDirections operates as a virtual drug development services company offering an integrated platform of consulting and execution services rather than a standalone software product. The core offering is the Drug Development Services platform, supplemented by eight specialized service modules: Program & Project Management, Drug Discovery Services, CMC & Quality Management, Preclinical Expert Services, Predictive Pharmacokinetic Modeling, Regulatory Affairs Services, Intellectual Property Inventors, and Dosage Form Development. These services are delivered through a virtual team model — combining a core staff of senior experts and PMP-certified project managers with a network of 200+ associates and contract research organizations — enabling small biotech companies to access big-pharma-level expertise without maintaining a full-time in-house team. The services span the full drug development lifecycle from discovery through regulatory approval, with each module available individually or as part of a full integrated program.

Product and service7 records
1Drug Development Services
CategoryDrug Development Services
2Program & Project Management
CategoryProgram & Project Management
3Drug Discovery Services
CategoryDrug Discovery Services
4CMC & Quality Management
CategoryCMC & Quality Management
5Preclinical Expert Services
CategoryPreclinical Research Services
6Predictive Pharmacokinetic Modeling
CategoryPharmacokinetic Modeling Services
7Regulatory Affairs Services
CategoryRegulatory Affairs Services
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-08-25
Description

Danforth Advisors announced the acquisition of PharmaDirections on August 25, 2025. This acquisition expands Danforth's integrated drug development services from discovery through commercialization. The move enhances Danforth's capabilities in supporting life science companies throughout drug development stages.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Drug development consulting and modeling & simulation firm with biosimulation tools. Direct overlap with PharmaDirections' pharmacokinetic modeling and regulatory strategy services for small biotech sponsors.

TypeBroad incumbent
Description

Large full-service CRO with significant small/mid biotech exposure and a cross-functional development offering. Competes with PharmaDirections for biotech-sponsored programs at larger scale.

TypeBroad incumbent
Description

Global CRO offering drug development services across all phases, including dedicated biotech-focused units. Overlaps with PharmaDirections in biotech development support but at much larger scale.

TypeDirect peer
Description

Mid-sized CRO focused on small and mid-sized biotech clients across the full drug development lifecycle. Directly comparable to PharmaDirections' full-spectrum, small-biotech-focused virtual development model.

TypeDirect peer
Description

Mid-sized CRO with strong small and mid-biotech focus and full-spectrum drug development capabilities including regulatory, biostatistics, and clinical operations. Comparable scale and client profile to PharmaDirections.

TypeBroad incumbent
Description

Largest CRO with end-to-end drug development capabilities and proprietary data assets. Competes for biotech contracts while also serving large pharma, making it a broad incumbent versus PharmaDirections' boutique focus.

TypeBroad incumbent
Description

Established CRO/CDMO with discovery, preclinical, and clinical development capabilities. Comparable CMC, preclinical, and regulatory services to PharmaDirections but with manufacturing infrastructure.

TypeEmerging player
Description

CRO/CDMO providing CMC, bioanalytical, and preclinical services to biotech and pharma. Overlaps with PharmaDirections' CMC, preclinical, and regulatory offerings.

TypeDirect peer
Description

Pharmaceutical consulting and CRO providing regulatory, CMC, and drug development services to small and mid-sized pharma/biotech. Closely comparable service mix and client profile to PharmaDirections.

TypeEmerging player
Description

CRO/CDMO offering drug discovery, preclinical, and CMC services tailored to small and emerging biotech. Comparable virtual-leaning service model and biotech client focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmaDirections

Pharmaceutical Drug Development Servicespharmadirections.com

PharmaDirections firmographics

Firmographics
Name
PharmaDirections
Legal name
PharmaDirections, Inc.
Website
https://pharmadirections.com
Company type
Private
Founded year
2003
Operating status
Acquired
Headcount range
11–50 employees
Ownership category
akta.pro rank

PharmaDirections industry classification

Industry
Product category
Pharmaceutical Drug Development Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Drug development consulting
  • Pharmaceutical regulatory affairs
  • Preclinical research services
  • CMC consulting services
  • Biotech program management

Where PharmaDirections is headquartered

Location

Headquarters

HQ city
Cary
HQ country
United States
HQ region
North America

Offices5 records

Markets served

PharmaDirections business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Drug Development Consulting Services: Professional services revenue from providing virtual drug development expertise to small biotech companies. Services span from discovery through commercialization, including regulatory affairs, CMC, preclinical, program management, and strategic consulting.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

PharmaDirections product offering

Product offering

Core offering

PharmaDirections is a virtual drug development company that provides consulting and execution services to small, start-up, and micro-biotech companies. The firm delivers expert support across the full drug development lifecycle, from discovery through regulatory approval, acting as an outsourced drug development partner for resource-constrained biotech sponsors.

Product overview

PharmaDirections operates as a virtual drug development services company offering an integrated platform of consulting and execution services rather than a standalone software product. The core offering is the Drug Development Services platform, supplemented by eight specialized service modules: Program & Project Management, Drug Discovery Services, CMC & Quality Management, Preclinical Expert Services, Predictive Pharmacokinetic Modeling, Regulatory Affairs Services, Intellectual Property Inventors, and Dosage Form Development. These services are delivered through a virtual team model — combining a core staff of senior experts and PMP-certified project managers with a network of 200+ associates and contract research organizations — enabling small biotech companies to access big-pharma-level expertise without maintaining a full-time in-house team. The services span the full drug development lifecycle from discovery through regulatory approval, with each module available individually or as part of a full integrated program.

Differentiator

Problem solved

Functional benefit

Products and services

  • Drug Development Services
  • Program & Project Management
  • Drug Discovery Services
  • CMC & Quality Management
  • Preclinical Expert Services
  • Predictive Pharmacokinetic Modeling
  • Regulatory Affairs Services

Quantifiable outcome

  • 45+ patents and patent applications generated for clients
  • +3 more outcomes

Companies that use PharmaDirections

Customer profile

Named customers19 records

Segments3 records

Ideal customer profiles1 record

PharmaDirections technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature2 records

PharmaDirections partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Danforth AdvisorsmajorStrategic or Co-development Partner · 25 August 2025Danforth Advisors announced the acquisition of PharmaDirections on August 25, 2025. This acquisition expands Danforth's integrated drug development services from discovery through commercialization. The move enhances Danforth's capabilities in supporting life science companies throughout drug development stages.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

PharmaDirections competitors and assessment

Company assessment

Direct peers

  • Certara: Drug development consulting and modeling & simulation firm with biosimulation tools. Direct overlap with PharmaDirections' pharmacokinetic modeling and regulatory strategy services for small biotech sponsors.
  • Worldwide Clinical Trials: Mid-sized CRO focused on small and mid-sized biotech clients across the full drug development lifecycle. Directly comparable to PharmaDirections' full-spectrum, small-biotech-focused virtual development model.
  • Rho: Mid-sized CRO with strong small and mid-biotech focus and full-spectrum drug development capabilities including regulatory, biostatistics, and clinical operations. Comparable scale and client profile to PharmaDirections.
  • ProPharma Group: Pharmaceutical consulting and CRO providing regulatory, CMC, and drug development services to small and mid-sized pharma/biotech. Closely comparable service mix and client profile to PharmaDirections.

Broad incumbents

  • Medpace: Large full-service CRO with significant small/mid biotech exposure and a cross-functional development offering. Competes with PharmaDirections for biotech-sponsored programs at larger scale.
  • ICON plc: Global CRO offering drug development services across all phases, including dedicated biotech-focused units. Overlaps with PharmaDirections in biotech development support but at much larger scale.
  • IQVIA: Largest CRO with end-to-end drug development capabilities and proprietary data assets. Competes for biotech contracts while also serving large pharma, making it a broad incumbent versus PharmaDirections' boutique focus.
  • Charles River Laboratories: Established CRO/CDMO with discovery, preclinical, and clinical development capabilities. Comparable CMC, preclinical, and regulatory services to PharmaDirections but with manufacturing infrastructure.

Emerging players

  • Frontage Laboratories: CRO/CDMO providing CMC, bioanalytical, and preclinical services to biotech and pharma. Overlaps with PharmaDirections' CMC, preclinical, and regulatory offerings.
  • BioDuro: CRO/CDMO offering drug discovery, preclinical, and CMC services tailored to small and emerging biotech. Comparable virtual-leaning service model and biotech client focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

PharmaDirections social profiles

Digital presence

PharmaDirections compliance and trust

Trust signal

Compliance1 record

PharmaDirections financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmaDirections leadership team

Management profile

Number of profiles

PharmaDirections funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmaDirections M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaDirections

What does PharmaDirections do?

PharmaDirections is a virtual drug development company that provides consulting and execution services to small, start-up, and micro-biotech companies. The firm delivers expert support across the full drug development lifecycle, from discovery through regulatory approval, acting as an outsourced drug development partner for resource-constrained biotech sponsors.

Is PharmaDirections a public or private company?

PharmaDirections is a private company. It is classified as corporate owned and is currently acquired.

When was PharmaDirections founded?

PharmaDirections was founded in 2003. It employs 11 to 50 people.

Where is PharmaDirections based?

PharmaDirections is headquartered in Cary, United States, in the North America region.

How does PharmaDirections make money?

One revenue line is on record: drug Development Consulting Services.

Who are PharmaDirections's main competitors?

Direct peers on record are Certara, Worldwide Clinical Trials, Rho and ProPharma Group. Broad incumbents are Medpace, ICON plc, IQVIA and Charles River Laboratories. Emerging players are Frontage Laboratories and BioDuro.

Does PharmaDirections have an API?

No public API is recorded for PharmaDirections.

What industry is PharmaDirections in?

PharmaDirections's product category is Pharmaceutical Drug Development Services. Its primary akta.pro industry code is HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals